Jun 24, 2022 11:56 AM IST

Strides Pharma announces results of SARS-CoV-2 vaccine clinical trial in India

The vaccine was well tolerated with no significant safety concerns and a seroconversion rate of 91%

Anthony Fauci says he's ''example'' for COVID-19 vaccinations

Speaking during a White House briefing, Fauci, 81, said he began experiencing virus symptoms on June 14 and tested positive a day later. He was prescribed the anti-viral drug paxlovid, which has proven to be highly effective at preventing serious illness and death from COVID-19, on June 15.

Fatigue, Stomach Aches, Mood Swings, Memory Lapses Top Long Covid Symptoms in Kids Aged 0-14: Lancet Study

In this research, surveys were sent to the mothers or guardians of children 0-14 years of age who had tested positive for Covid-19 between January 2020 and July 2021

Paraguay cancels order for one million Covaxin doses citing quality issues: Reports

Bharat Biotech did not immediately react to the development, but company sources reportedly said that all export orders already stand cancelled as the production has been halted.

India resists move by developed countries to dilute TRIPS waiver for COVID vaccines before WTO meet

Rich economies such as the United States, European Union, United Kingdom and Canada have till now blocked a plan to temporarily waive global Intellectual Property Rights rules for COVID-19 vaccines at the WTO. Now they are actively diluting it before the all-powerful Ministerial Conference on June 12 in Geneva.

Some short-term benefit of additional booster dose of mRNA vaccine in health workers: WHO

As a general principle, an interval of 4-6 months since completion of the primary series of the vaccine could be considered for a first booster, especially in the context of Omicron, said the World Health Organisation, with the support of the Strategic Advisory Group of Experts (SAGE) on immunisation and its COVID-19 Vaccines Working Group.

US FDA authorizes Pfizer's COVID booster shot for young children

The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine.

Ramp up Covid vaccination drive for children aged 12-14 years: UP CM to officials

Reviewing the Covid situation in the state, the chief minister said vaccinating all eligible children is the priority of the government and asked officials to ensure the availability of vaccines.

The White House plans for how to provide vaccines if there Is no more COVID-19 aid

Democrats have been contemplating wrapping COVID-19 aid into another emergency package for Ukraine, but it was unclear whether they will do so.

SII's COVID-19 vaccine Covovax now available for 12-17 age group at private centres

A dose of Covovax will cost Rs 900 plus GST at private vaccination centres, in addition to a hospital service charge of Rs 150.

COVID-19 shots still work but researchers hunt new improvements

Moderna and Pfizer are testing 2-in-1 COVID-19 protection that they hope to offer this fall. Each bivalent shot would mix the original, proven vaccine with an omicron-targeted version.

What does new-born health insurance cover pay for?

Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt

New Delhi, Apr 12 Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose..

Don't panic, but follow COVID norms, be vigilant: Doctors on rise in Delhi's positivity rate

Doctors also said that the city government should increase the number of COVID tests, and while the positivity rate has been on the rise, the number of coronavirus patients getting admitted to hospital is still less.

For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

"In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," the SII chief executive said.

CNBC TV18's IBLA 2022: SII CEO Adar Poonawalla gets award for 'Outstanding Business Leader of the Year'

Serum Institute of India invested in Covishield -- the India-manufactured version of the Oxford-AstraZeneca vaccine against COVID-19 -- on an "at-risk" basis in March 2020, created regulatory hurdles and released the vaccine in a matter of nine months.

West Bengal to roll out vaccination drive for children aged 12-14 years from March 21

The beneficiaries would be administered only Corbevax and they can book their slots online though the facility of on-site registration will also be available, a state government notification said on Thursday.

Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine

The Centre has asked states to organise dedicated Covid vaccination sessions through earmarked centres and train vaccinators to avoid mixing of vaccines during the inoculation of children in the 12-14 age group.

COVID-19 vaccination of children in 12-14 age group begins; low turnout on day 1

Day one of the exercise saw children arriving largely through 'walk-in for vaccination' and the numbers were very few at session sites.

COVID-19 vaccination for children aged 12-14 starts today

Besides, the government has also decided to waive the condition of comorbidity for those above 60 years in order to receive the precaution dose.

COVID-19 | Centre releases guidelines for vaccination of children aged 12-14 years

As per the Centre’s guidelines, only Biological E’s Corbevax coronavirus vaccine will be administered to the beneficiaries in this age group. Two doses of the intramuscular vaccine would be administered to kids aged 12 to 14 years at an interval of 28 days.

COVID-19 vaccination for children in 12-15 years group to begin this week: Official sources

Biological E's Corbevax will be administered to 12-15 years age-group.

COVID-19 vaccine: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

Covovax is manufactured by technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorisation and has also been granted emergency use listing by WHO.

Experts question IIT-K study predicting fourth COVID-19 wave in India in June

“Active cases are decreasing quite fast — and from looking at the current trends we certainly cannot say anything about a new wave in the future,” said Sithabra Sinha, professor at Chennai's Institute of Mathematical Sciences (IMSc).

Why India must achieve full vaccination coverage quickly

As new age groups are added to the eligible population, it's essential to move quickly to attain full coverage and bring the pandemic to an end